Rothschild Investment LLC Castle Biosciences Inc Call Options Transaction History
Rothschild Investment LLC
- $1.6 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CSTL
# of Institutions
165Shares Held
27.2MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$58.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$42 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$34.8 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$28.8 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$26.7 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $509M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...